Episode #89: End of Alzheimer's with Dr. Dale Bredesen, MD

Why You Should Listen: In this episode, you will learn the factors involved in dementia and Alzheimer's and potential solutions discussed in "The End of Alzheimer's". About My Guest: My guest for this episode is Dr. Dale Bredesen.  Dale Bredesen, MD is internationally recognized as an expert in the mechanisms of neurodegenerative diseases such as Alzheimer's disease. He graduated from Caltech, then earned his MD from Duke University Medical Center in Durham, NC. He served as Chief Resident in Neurology at the University of California, San Francisco (UCSF) before joining Nobel laureate Stanley Prusiner's laboratory at UCSF as an NIH Postdoctoral Fellow. He held faculty positions at UCSF, UCLA and the University of California, San Diego. Dr. Bredesen directed the Program on Aging at the Burnham Institute before coming to the Buck Institute in 1998 as its founding President and CEO. The uniform failure of recent drug trials in Alzheimer's disease has highlighted the critical need for a more accurate understanding of the fundamental nature of Alzheimer's disease. Dr. Bredesen's research has led to new insights that explain the erosion of memory seen in Alzheimer's disease, and these insights have opened the door to a new therapeutic approach. His book "The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline" was released just over a year ago and is a hopeful exploration into not only the condition, but to solutions that are helping people with Alzheimer's improve their quality of life today. Key Takeaways: How big of a problem is Alzheimer's? What is the role of apoE in the potential for Alzheimer's development? What are the primary risk factors for the development of Alzheimer's? Why is amyloid a potentially a good thing and not something to focus on removing without first addressing underlying causes? What are the subtypes of Alzheimer's? How does insulin sensitivity play a role om Alzheimer's? What factors play a role in the the "Toxic" subtype 3? What is the role of Lyme disease and mold illness in the development of Alzheimer's? What is a "Cognoscopy" and how is it performed? What is the "ReCode" protocol and how is treatment approached? How are VIP and Synapsin potentially helpful in reversing cognitive decline? Does Mast Cell Activation Syndrome play a role in the inflammation associated with Alzheimer's? Is detoxification important in recovering cognitive function? Which binders are helpful in supporting detoxification? Does EMF exposure play a role in the development of Alzheimer's? Connect With My Guest: https://ApolloHealthCo.com Interview Date: January 16, 2019 Additional Information: To learn more, visit https://BetterHealthGuy.com. Disclaimer: The content of this show is for informational purposes only and is not intended to diagnose, treat, or cure any illness or medical condition. Nothing in today's discussion is meant to serve as medical advice or as information to facilitate self-treatment. As always, please discuss any potential health-related decisions with your own personal medical authority.